{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:58:19Z","timestamp":1794473899871,"version":"4.9.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["19 0008 Pj 01 H"],"award-info":[{"award-number":["19 0008 Pj 01 H"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Lions Cancer Research Foundation","award":["1050097"],"award-info":[{"award-number":["1050097"]}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2015-02711"],"award-info":[{"award-number":["2015-02711"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Human papillomavirus (HPV) testing is recommended in primary cervical screening to improve cancer prevention. An advantage of HPV testing is that it can be performed on self-samples, which could increase population coverage and result in a more efficient strategy to identify women at risk of developing cervical cancer. Our objective was to assess whether repeated self-sampling for HPV testing is cost-effective in comparison with Pap smear cytology for detection of cervical intraepithelial neoplasia grade 2 or more (CIN2+) in increasing participation rate in primary cervical screening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A cost-effectiveness analysis (CEA) was performed on data from a previously published randomized clinical study including 36,390 women aged 30\u201349\u2009years. Participants were randomized either to perform repeated self-sampling of vaginal fluid for HPV testing (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200917,997, HPV self-sampling arm) or to midwife-collected Pap smears for cytological analysis (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200918,393, Pap smear arm).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Self-sampling for HPV testing led to 1633 more screened women and 107 more histologically diagnosed CIN2+ at a lower cost vs. midwife-collected Pap smears (\u20ac 229,446 vs. \u20ac 782,772).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study resulted in that repeated self-sampling for HPV testing increased participation and detection of CIN2+ at a lower cost than midwife-collected Pap smears in primary cervical screening. Offering women a home-based self-sampling may therefore be a more cost-effective alternative than clinic-based screening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>Not registered since this trial is a secondary analysis of an earlier published study (Gustavsson et al., British journal of cancer. 118:896-904, 2018).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-020-07085-9","type":"journal-article","created":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T07:04:10Z","timestamp":1594623850000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6752-531X","authenticated-orcid":false,"given":"Riina","family":"Aarnio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellinor","family":"\u00d6stensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matts","family":"Olovsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger","family":"Gustavsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Gyllensten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,13]]},"reference":[{"issue":"15","key":"7085_CR1","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1016\/j.ejca.2009.07.018","volume":"45","author":"M Arbyn","year":"1990","unstructured":"Arbyn M. Trends of cervical cancer mortality in the member states of the European Union. Eur J Cancer. 1990;45(15):2640\u20138.","journal-title":"Eur J Cancer"},{"key":"7085_CR2","unstructured":"NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 8.2 (26.03.2019). Association of the Nordic Cancer Registries. Danish Cancer Society. Available from http:\/\/www.ancr.nu, Accessed 2 May 2019."},{"issue":"1","key":"7085_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12\u20139.","journal-title":"J Pathol"},{"issue":"16","key":"7085_CR4","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1056\/NEJMoa073204","volume":"357","author":"P Naucler","year":"2007","unstructured":"Naucler P, Ryd W, Tornberg S, Strand A, Wadell G, Elfgren K, et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med. 2007;357(16):1589\u201397.","journal-title":"N Engl J Med"},{"issue":"16","key":"7085_CR5","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1056\/NEJMoa071430","volume":"357","author":"MH Mayrand","year":"2007","unstructured":"Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med. 2007;357(16):1579\u201388.","journal-title":"N Engl J Med"},{"key":"7085_CR6","unstructured":"European guidelines for quality assurance in cervical cancer screening \u2013 second edition. 2015. http:\/\/www.gisci.it\/documenti\/news\/EW0115451ENN_002.pdf. Accessed 13 Jan 2020."},{"issue":"9916","key":"7085_CR7","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","volume":"383","author":"G Ronco","year":"2014","unstructured":"Ronco G, Dillner J, Elfstr\u00f6m KM, Tunesi S, Snijders PJF, Arbyn M, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014;383(9916):524\u201332.","journal-title":"Lancet"},{"issue":"8","key":"7085_CR8","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1002\/ijc.30609","volume":"140","author":"SBP Mittal","year":"2017","unstructured":"Mittal SBP, Muwonge R, Banerjee D, Ghosh I, Sengupta MM, Das P, Dey P, Mandal R, Panda C, Biswas J, Sankaranarayanan R. Risk of high-grade precancerous lesions and invasive cancers in high-risk HPV-positive women with normal cervix or CIN 1 at baseline-a population-based cohort study. Int J Cancer. 2017;140(8):1850\u20139.","journal-title":"Int J Cancer"},{"issue":"5","key":"7085_CR9","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/bjc.2011.277","volume":"105","author":"U Gyllensten","year":"2011","unstructured":"Gyllensten U, Sanner K, Gustavsson I, Lindell M, Wikstrom I, Wilander E. Short-time repeat high-risk HPV testing by self-sampling for screening of cervical cancer. Br J Cancer. 2011;105(5):694\u20137.","journal-title":"Br J Cancer"},{"key":"7085_CR10","doi-asserted-by":"crossref","unstructured":"Andrae B. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst. 2008;100(9):622\u20139.","DOI":"10.1093\/jnci\/djn099"},{"issue":"3","key":"7085_CR11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/bjc.2011.236","volume":"105","author":"I Wikstrom","year":"2011","unstructured":"Wikstrom I, Lindell M, Sanner K, Wilander E. Self-sampling and HPV testing or ordinary pap-smear in women not regularly attending screening: a randomised study. Br J Cancer. 2011;105(3):337\u20139.","journal-title":"Br J Cancer"},{"issue":"2","key":"7085_CR12","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1471-0528.2011.03147.x","volume":"119","author":"M Lindell","year":"2012","unstructured":"Lindell M, Sanner K, Wikstrom I, Wilander E. Self-sampling of vaginal fluid and high-risk human papillomavirus testing in women aged 50 years or older not attending Papanicolaou smear screening. BJOG. 2012;119(2):245\u20138.","journal-title":"BJOG"},{"issue":"1","key":"7085_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcv.2013.06.029","volume":"58","author":"L Darlin","year":"2013","unstructured":"Darlin L, Borgfeldt C, Forslund O, Henic E, Hortlund M, Dillner J, et al. Comparison of use of vaginal HPV self-sampling and offering flexible appointments as strategies to reach long-term non-attending women in organized cervical screening. J Clin Virol. 2013;58(1):155\u201360.","journal-title":"J Clin Virol"},{"issue":"9","key":"7085_CR14","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1002\/ijc.28545","volume":"134","author":"G Broberg","year":"2014","unstructured":"Broberg G, Gyrd-Hansen D, Miao Jonasson J, Ryd ML, Holtenman M, Milsom I, et al. Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial. Int J Cancer. 2014;134(9):2223\u201330.","journal-title":"Int J Cancer"},{"issue":"16","key":"7085_CR15","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.ejca.2015.07.006","volume":"51","author":"F Verdoodt","year":"2015","unstructured":"Verdoodt F, Jentschke M, Hillemanns P, Racey CS, Snijders PJ, Arbyn M. Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials. Eur J Cancer. 2015;51(16):2375\u201385.","journal-title":"Eur J Cancer"},{"issue":"11","key":"7085_CR16","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1002\/ijc.32374","volume":"145","author":"KM Elfstrom","year":"2019","unstructured":"Elfstrom KM, Sundstrom K, Andersson S, Bzhalava Z, Carlsten Thor A, Gzoul Z, et al. Increasing participation in cervical screening by targeting long-term nonattenders: randomized health services study. Int J Cancer. 2019;145(11):3033\u20139.","journal-title":"Int J Cancer"},{"issue":"2","key":"7085_CR17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S1470-2045(13)70570-9","volume":"15","author":"M Arbyn","year":"2014","unstructured":"Arbyn M, Verdoodt F, Snijders PJ, Verhoef VM, Suonio E, Dillner L, et al. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol. 2014;15(2):172\u201383.","journal-title":"Lancet Oncol"},{"issue":"6","key":"7085_CR18","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/bjc.2017.485","volume":"118","author":"I Gustavsson","year":"2018","unstructured":"Gustavsson I, Aarnio R, Berggrund M, Hedlund-Lindberg J, Strand AS, Sanner K, et al. Randomised study shows that repeated self-sampling and HPV test has more than two-fold higher detection rate of women with CIN2+ histology than pap smear cytology. Br J Cancer. 2018;118(6):896\u2013904.","journal-title":"Br J Cancer"},{"key":"7085_CR19","volume-title":"O\u2019Brian BJ, Stoddart GL. Methods for the economic Evalutaion of Helath care Programmes. Edition r, editor","author":"M Drummond","year":"2005","unstructured":"Drummond M, Schulper M, Torrance GW. O\u2019Brian BJ, Stoddart GL. Methods for the economic Evalutaion of Helath care Programmes. Edition r, editor. Oxford: Oxford university press; 2005."},{"key":"7085_CR20","volume-title":"Consumer Price Index (CPI): Statistics Sweden","author":"ScB","year":"2019","unstructured":"ScB. Consumer Price Index (CPI): Statistics Sweden; 2019. Available from: https:\/\/www.scb.se\/en\/finding-statistics\/statistics-by-subject-area\/prices-and-consumption\/. [cited 2019 Mar 21]."},{"issue":"3","key":"7085_CR21","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/BF03404377","volume":"101","author":"A Vijayaraghavan","year":"2010","unstructured":"Vijayaraghavan A, Efrusy MB, Mayrand MH, Santas CC, Goggin P. Cost-effectiveness of high-risk human papillomavirus testing for cervical cancer screening in Quebec, Canada. Can J Public Health. 2010;101(3):220\u20135.","journal-title":"Can J Public Health"},{"issue":"9","key":"7085_CR22","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1002\/ijc.25211","volume":"127","author":"J Berkhof","year":"2010","unstructured":"Berkhof J, Coupe VM, Bogaards JA, van Kemenade FJ, Helmerhorst TJ, Snijders PJ, et al. The health and economic effects of HPV DNA screening in the Netherlands. Int J Cancer. 2010;127(9):2147\u201358.","journal-title":"Int J Cancer"},{"issue":"2","key":"7085_CR23","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1016\/S2468-2667(17)30007-5","volume":"2","author":"JB Lew","year":"2017","unstructured":"Lew JB, Simms KT, Smith MA, Hall M, Kang YJ, Xu XM, et al. Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program. Lancet Public Health. 2017;2(2):e96\u2013e107.","journal-title":"Lancet Public Health"},{"issue":"2","key":"7085_CR24","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ygyno.2016.08.231","volume":"143","author":"K Pedersen","year":"2016","unstructured":"Pedersen K, Burger EA, Sy S, Kristiansen IS, Kim JJ. Cost-effective management of women with minor cervical lesions: revisiting the application of HPV DNA testing. Gynecol Oncol. 2016;143(2):326\u201333.","journal-title":"Gynecol Oncol"},{"issue":"11","key":"7085_CR25","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1038\/bjc.2014.510","volume":"111","author":"K Haguenoer","year":"2014","unstructured":"Haguenoer K, Sengchanh S, Gaudy-Graffin C, Boyard J, Fontenay R, Marret H, et al. Vaginal self-sampling is a cost-effective way to increase participation in a cervical cancer screening programme: a randomised trial. Br J Cancer. 2014;111(11):2187\u201396.","journal-title":"Br J Cancer"},{"issue":"1","key":"7085_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1158\/1055-9965.EPI-16-0350","volume":"26","author":"EA Burger","year":"2017","unstructured":"Burger EA, Sy S, Nygard M, Kim JJ. The cost-effectiveness of cervical self-sampling to improve routine cervical Cancer screening: the importance of respondent screening history and compliance. Cancer Epidemiol Biomark Prev. 2017;26(1):95\u2013103.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"5","key":"7085_CR27","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1158\/1055-9965.EPI-14-0998","volume":"24","author":"K Rozemeijer","year":"2015","unstructured":"Rozemeijer K, de Kok IM, Naber SK, van Kemenade FJ, Penning C, van Rosmalen J, et al. Offering self-sampling to non-attendees of organized primary HPV screening: when do harms outweigh the benefits? Cancer Epidemiol Biomark Prev. 2015;24(5):773\u201382.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"2","key":"7085_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/0969141317704679","volume":"25","author":"A Tsiachristas","year":"2018","unstructured":"Tsiachristas A, Gittins M, Kitchener H, Gray A. Cost-effectiveness of strategies to increase cervical screening uptake at first invitation (STRATEGIC). J Med Screen. 2018;25(2):99\u2013109.","journal-title":"J Med Screen"},{"issue":"1","key":"7085_CR29","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ygyno.2019.01.021","volume":"153","author":"P Vassilakos","year":"2019","unstructured":"Vassilakos P, Poncet A, Catarino R, Viviano M, Petignat P, Combescure C. Cost-effectiveness evaluation of HPV self-testing offered to non-attendees in cervical cancer screening in Switzerland. Gynecol Oncol. 2019;153(1):92\u20139.","journal-title":"Gynecol Oncol"},{"key":"7085_CR30","doi-asserted-by":"crossref","unstructured":"Asciutto KC, Henic E, Darlin L, Forslund O, Borgfeldt C. Follow up with HPV test and cytology as test of cure, 6 months after conization, is reliable. Acta Obstet Gynecol Scand. 2016;95(11):1251\u20137.","DOI":"10.1111\/aogs.12960"},{"issue":"3","key":"7085_CR31","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.ygyno.2013.12.040","volume":"132","author":"AF Rositch","year":"2014","unstructured":"Rositch AF, Soeters HM, Offutt-Powell TN, Wheeler BS, Taylor SM, Smith JS. The incidence of human papillomavirus infection following treatment for cervical neoplasia: a systematic review. Gynecol Oncol. 2014;132(3):767\u201379.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"7085_CR32","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s11845-015-1392-4","volume":"185","author":"M Molloy","year":"2016","unstructured":"Molloy M, Comer R, Rogers P, Dowling M, Meskell P, Asbury K, et al. High risk HPV testing following treatment for cervical intraepithelial neoplasia. Ir J Med Sci. 2016;185(4):895\u2013900.","journal-title":"Ir J Med Sci"},{"issue":"5","key":"7085_CR33","doi-asserted-by":"publisher","first-page":"e0128270","DOI":"10.1371\/journal.pone.0128270","volume":"10","author":"E Ostensson","year":"2015","unstructured":"Ostensson E, Alder S, Elfstrom KM, Sundstrom K, Zethraeus N, Arbyn M, et al. Barriers to and facilitators of compliance with clinic-based cervical cancer screening: population-based cohort study of women aged 23-60 years. PLoS One. 2015;10(5):e0128270.","journal-title":"PLoS One"},{"issue":"7","key":"7085_CR34","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1111\/aogs.12143","volume":"92","author":"E Ostensson","year":"2013","unstructured":"Ostensson E, Hellstrom AC, Hellman K, Gustavsson I, Gyllensten U, Wilander E, et al. Projected cost-effectiveness of repeat high-risk human papillomavirus testing using self-collected vaginal samples in the Swedish cervical cancer screening program. Acta Obstet Gynecol Scand. 2013;92(7):830\u201340.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"7085_CR35","unstructured":"Strander Bea. Nationellt v\u00e5rdprogram f\u00f6r prevention av livmoderhalscancer 2017 [updated 2018-12-11."},{"key":"7085_CR36","unstructured":"Screening f\u00f6r livmoderhalscancer \u2013 Rekommendation och bed\u00f6mningsunderlag. 2015."}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07085-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-020-07085-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07085-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T19:30:48Z","timestamp":1626118248000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-07085-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,13]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["7085"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-07085-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-29338\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-29338\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-29338\/v3","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,13]]},"assertion":[{"value":"13 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Regional Ethics Committee in Uppsala (Dnr 2012\/099). Participants received written information and consent was given by opt-in, as approved by the Ethics Committee. Women were sent an invitation with a self-sampling kit and if they agreed to participate they performed self-sampling and sent the sample to the laboratory.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"645"}}